Year |
Citation |
Score |
2014 |
Hutson LW, Szczytkowski JL, Saurer TB, Lebonville C, Fuchs RA, Lysle DT. Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation. Brain, Behavior, and Immunity. 38: 118-24. PMID 24462948 DOI: 10.1016/J.Bbi.2014.01.008 |
0.647 |
|
2009 |
Saurer TB, Ijames SG, Lysle DT. Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations. The Journal of Pharmacology and Experimental Therapeutics. 329: 1040-7. PMID 19258519 DOI: 10.1124/jpet.108.148627 |
0.792 |
|
2008 |
Saurer TB, Ijames SG, Carrigan KA, Lysle DT. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain, Behavior, and Immunity. 22: 89-97. PMID 17689049 DOI: 10.1016/J.Bbi.2007.06.009 |
0.79 |
|
2006 |
Saurer TB, Ijames SG, Lysle DT. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. Journal of Neuroimmunology. 177: 18-26. PMID 16766046 DOI: 10.1016/j.jneuroim.2006.05.002 |
0.814 |
|
2006 |
Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. Journal of Neuroimmunology. 173: 3-11. PMID 16364456 DOI: 10.1016/J.Jneuroim.2005.11.009 |
0.8 |
|
2006 |
Saurer TB, Ijames SG, Lysle DT. Opioid-induced increases in nucleus accumbens dopamine may modulate immune status via the sympathetic nervous system Brain, Behavior, and Immunity. 20: 61. DOI: 10.1016/j.bbi.2006.04.138 |
0.759 |
|
2005 |
Saurer TB, Carrigan KA, Ijames SG, Lysle DT. #121 A role for neuropeptide Y in the suppression of natural killer cell activity by morphine Brain, Behavior, and Immunity. 19: e63. DOI: 10.1016/J.Bbi.2005.10.128 |
0.753 |
|
2004 |
Carrigan KA, Saurer TB, Ijames SG, Lysle DT. Buprenorphine produces naltrexone reversible alterations of immune status. International Immunopharmacology. 4: 419-28. PMID 15037219 DOI: 10.1016/J.Intimp.2004.01.011 |
0.776 |
|
2004 |
Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. Journal of Neuroimmunology. 148: 54-62. PMID 14975586 DOI: 10.1016/J.Jneuroim.2003.11.006 |
0.791 |
|
Show low-probability matches. |